CVS Health (NYSE:CVS) Stock Price Down 0.1% – Should You Sell?

CVS Health Co. (NYSE:CVS)’s stock price was down 0.1% during trading on Wednesday . The company traded as low as $52.34 and last traded at $53.08. Approximately 2,169,597 shares changed hands during mid-day trading, a decline of 84% from the average daily volume of 13,347,702 shares. The stock had previously closed at $53.15.

Analysts Set New Price Targets

A number of equities analysts have weighed in on CVS shares. UBS Group boosted their target price on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research note on Thursday, November 7th. Mizuho dropped their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price for the company in a research note on Tuesday, December 3rd. Barclays lowered their target price on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research note on Thursday, November 7th. Finally, Piper Sandler reduced their price target on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a report on Monday, November 25th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $68.71.

CVS Health Price Performance

The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The company’s 50-day simple moving average is $51.21 and its 200-day simple moving average is $56.22. The stock has a market capitalization of $68.84 billion, a P/E ratio of 13.88, a price-to-earnings-growth ratio of 0.80 and a beta of 0.59.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.01. The company had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The company’s revenue was up 6.3% on a year-over-year basis. During the same period in the prior year, the firm earned $2.21 earnings per share. As a group, sell-side analysts expect that CVS Health Co. will post 5.22 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.86%. The ex-dividend date is Thursday, January 23rd. CVS Health’s payout ratio is presently 67.51%.

Hedge Funds Weigh In On CVS Health

Hedge funds have recently bought and sold shares of the business. MidAtlantic Capital Management Inc. bought a new position in CVS Health during the third quarter worth about $25,000. Ridgewood Investments LLC increased its position in CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 450 shares during the period. Livelsberger Financial Advisory bought a new position in CVS Health during the third quarter worth about $31,000. Legacy Investment Solutions LLC bought a new position in CVS Health during the third quarter worth about $31,000. Finally, Reston Wealth Management LLC bought a new position in CVS Health during the third quarter worth about $32,000. 80.66% of the stock is owned by institutional investors.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.